Cancer Tumor Profiling Global Market Report 2023 – Cancer Tumor Profiling Global Market Report 2023 – By Cancer Type (Lung Cancer Breast Cancer Colorectal Cancer Prostate Cancer Melanoma Ovarian Cancer Stomach Cancer Pancreatic Cancer Thyroid Cancer Other Cancer Types), By Technology (Next-Generation Sequencing (NGS) Polymerase Chain Reaction (PCR) Immunohistochemistry (IHC) In Situ Hybridization (ISH) Microarray Other Technologies), By Process Type (Genomics Proteomics Epigenetics Metabolomics Other Types), By Application (Personalized Medicine Diagnostics Biomarker Discovery Prognostics Research Applications) – Market Size, Trends, And Global Forecast 2023-2032 ...(expand)
What is the definition of the cancer tumor profiling market?
The cancer tumor profiling market consists of sales of cancer tumor profiling technologies by entities (organization, partnership, sole traders) that refer to a laboratory test that examines a sample of tumor tissue for specific genes or gene mutations (changes), proteins, or other biomarkers. Tumor profiling can help with treatment planning as well as predicting if cancer will recur or spread to other parts of the body. request a sample here
How will the cancer tumor profiling market drivers and restraints affect cancer tumor profiling market dynamics? What forces will shape the cancer tumor profiling industry going forward?
The cancer tumor profiling market growth is aided by the increasing incidences of cancer. request a sample here
What is the forecast market size of the cancer tumor profiling market?
The cancer tumor profiling market is expected to reach $15.96 billion in 2026 at a rate of 13.6%. request a sample here
How is the cancer tumor profiling segmented?
The global cancer tumor profiling market is segmented -
1) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Others 2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Others 3) By Process Type: Genomics, Proteomics, Epigenetics, Metabolomics, Others 4) By Application: Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications request a sample here
Which region has largest share, and what is the market size and growth by geography according to the cancer tumor profiling global market report?
North America was the largest region in cancer and tumor profiling market in 2021. Asia-Pacific is expected to be the fastest-growing region in the global cancer tumor profiling market during the forecast period. request a sample here.
Who are the key players of the cancer tumor profiling market?
Top competitors in the cancer tumor profiling market are F. Hoffmann-La Roche Ltd, Caris Life Sciences, Thermo Fisher Scientific Inc., Illumina Inc., QIAGEN, Ribomed Biotechnologies Inc., HTG Molecular Diagnostics Inc., NanoString, NeoGenomics Laboratories, Lucence Health Inc., ACT Genomics Co. LTD, Strand Life Sciences, IMB Dx Inc., Exact Sciences Corporation (Genomic Health Inc.), Guardant Health, and Foundation Medicine Inc. request a sample here.
What are the key trends in the cancer tumor profiling market?
Major trends influencing the cancer tumor profiling market include increasing research and development activities. Major companies operating in the cancer and tumor profiling sector are focused on research and development activities to meet consumer demand and reinforce their position. request a sample here.
What are the major opportunities in the cancer tumor profiling market and the approaches companies can take to take advantage of them?
For detail on the future and current opportunities in the global cancer tumor profiling market, request a sample here. request a sample here.
How does the cancer tumor profiling market relate to the overall economy and other similar markets?
Get in touch to find out about our ReportsContact Us